Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer

被引:26
作者
Chang, Yu-Ling [1 ,2 ]
Tsai, Yun-Fang [3 ,4 ]
Chao, Yin-Kai [5 ]
Wu, Meng-Yu [6 ]
机构
[1] Chang Gung Mem Hosp, Dept Nursing, Taoyuan, Taiwan
[2] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan 333, Taiwan
[3] Chang Gung Univ, Coll Med, Sch Nursing, 259 Wen Hwa 1st Rd, Taoyuan 333, Taiwan
[4] Chang Gung Mem Hosp, Dept Nursing, Keelung, Taiwan
[5] Chang Gung Mem Hosp, Dept Thorac & Cardiovasc Surg, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Dept Cardiovasc Surg, Taoyuan, Taiwan
关键词
Esophagectomy; Esophageal cancer; QOL; Cancer recurrence; Survival; EORTC QLQ-C30; RECURRENCE; CARCINOMA; COMPLICATIONS; NEOADJUVANT; THERAPY; TERM; CHEMOTHERAPY; METAANALYSIS; RESECTION;
D O I
10.1007/s11136-015-1094-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose Improving survival after esophagectomy is an important issue in treating patients with esophageal cancer (EC). In addition to standard hospitalization management, periodic assessment of quality-of-life (QOL) measures may be useful to detect disease progression from patients' subjective reports. Therefore, this prospective longitudinal study was undertaken to identify prognostic factors for 3-year survival of EC patients after esophagectomy and to evaluate the impact of QOL measures on these prognostic factors. Methods Patients with EC (n = 67) who had a complete tumor resection and were alive 6 months after esophagectomy were followed in this study for 3 years. Data were collected on patients' sociodemographics, cancer characteristics, adjuvant therapy, general QOL and EC-specific QOL (before esophagectomy and 6 months afterward), cancer recurrence, and death. Patients' independent risk factors for 3-year survival were investigated by multivariate Cox regression analysis. Results Of the 67 participants with EC, 26 had late mortality, with a median survival for the whole cohort of 38.2 months (95 % CI 31.97-44.35). Independent predictors of early death were early cancer recurrence (within 6 months after surgery), poor cognitive function (95 % CI 1.020-1.041), and worse dyspnea (95 % CI 1.007-1.034). Conclusions The most predictive factor for early death in EC patients after esophagectomy was cancer recurrence within 6 months after surgery. However, QOL measures could be a tool to provide clinical information from patients' perspective suggesting cancer recurrence.
引用
收藏
页码:465 / 475
页数:11
相关论文
共 53 条
[1]   Brain vulnerability to chemotherapy toxicities [J].
Ahles, Tim A. .
PSYCHO-ONCOLOGY, 2012, 21 (11) :1141-1148
[2]   Neoadjuvant or Adjuvant Therapy for Resectable Esophageal Cancer: Is There a Standard of Care? [J].
Almhanna, Khaldoun ;
Shridhar, Ravi ;
Meredith, Kenneth L. .
CANCER CONTROL, 2013, 20 (02) :89-96
[3]  
American Joint Committee on Cancer, 2010, CANC STAGING MANUAL, P29
[4]   Surgical complications do not affect longterm survival after esophagectomy for carcinoma of the thoracic esophagus and cardia [J].
Ancona, Ermanno ;
Cagol, Matteo ;
Epifani, Magdalena ;
Cavallin, Francesco ;
Zaninotto, Giovanni ;
Castoro, Carlo ;
Alfieri, Rita ;
Ruol, Alberto .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (05) :661-669
[5]   Reducing hospital morbidity and mortality following esophagectomy [J].
Atkins, BZ ;
Shah, AS ;
Hutcheson, KA ;
Mangum, JH ;
Pappas, TN ;
Harpole, DH ;
D'Amico, TA .
ANNALS OF THORACIC SURGERY, 2004, 78 (04) :1170-1176
[6]   Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma [J].
Blazeby, JM ;
Sanford, E ;
Falk, SJ ;
Alderson, D ;
Donovan, JL .
CANCER, 2005, 103 (09) :1791-1799
[7]  
Campbell M.J., 2001, Statistics at square two: Understanding modern statistical applications in medicine
[8]  
CARRIERIKOHLMAN V, 2006, DYSPNOEA ADV DIS, P171
[9]   Factors Relating to Quality of Life After Esophagectomy for Cancer Patients in Taiwan [J].
Chang, Yu-Ling ;
Tsai, Yun-Fang ;
Wu, Yi-Cheng ;
Hsieh, Ming-Ju .
CANCER NURSING, 2014, 37 (01) :4-13
[10]   Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35 [J].
Chie, WC ;
Hong, RL ;
Lai, CC ;
Ting, LL ;
Hsu, MM .
QUALITY OF LIFE RESEARCH, 2003, 12 (01) :93-98